Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non–small-cell lung carcinoma

Epigenetic alterations are crucial to oncogenesis and regulation of gene expression in non–small-cell lung carcinoma (NSCLC). DNA methylation (DNAm) biomarkers may provide molecular-level prediction of relapse risk in cancer. Identification of optimal treatment is warranted for improving clinical ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ruihan, Song, Jing, Xiao, Xiao, Xie, Zhengbo, Zhao, Zhiyuan, Zhang, Wanfeng, Miao, Shiqi, Tang, Yongyao, Ran, Longke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425482/
https://www.ncbi.nlm.nih.gov/pubmed/32723974
http://dx.doi.org/10.18632/aging.103517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425482/
https://www.ncbi.nlm.nih.gov/pubmed/32723974
http://dx.doi.org/10.18632/aging.103517

Ejemplares similares